BDBM72174 (5E)-5-(6-oxidanylidenecyclohexa-2,4-dien-1-ylidene)-N-[2-(phenylcarbonyl)-1-benzofuran-3-yl]-1,2-dihydropyrazole-3-carboxamide::(5E)-N-(2-benzoyl-1-benzofuran-3-yl)-5-(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2-dihydropyrazole-3-carboxamide::(5E)-N-(2-benzoyl-3-benzofuranyl)-5-(6-oxo-1-cyclohexa-2,4-dienylidene)-1,2-dihydropyrazole-3-carboxamide::(5E)-N-(2-benzoylbenzofuran-3-yl)-5-(6-ketocyclohexa-2,4-dien-1-ylidene)-3-pyrazoline-3-carboxamide::5-(2-Hydroxy-phenyl)-2H-pyrazole-3-carboxylic acid (2-benzoyl-benzofuran-3-yl)-amide::MLS000331861::SMR000221422::cid_12004589
SMILES CC(C)C[C@@H](N)[C@H](O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(C)C)C(=O)NCCc1ccccc1
InChI Key InChIKey=CURFPPYRXGETPW-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 72174
Memorial Sloan-Kettering Cancer Center; Memorial Hospital for Cancer and Allied Diseases; Sloan-Kettering Institute for Cancer Research
US Patent
Memorial Sloan-Kettering Cancer Center; Memorial Hospital for Cancer and Allied Diseases; Sloan-Kettering Institute for Cancer Research
US Patent
